Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012Ranee Mehra, Robert I. Haddad, Iris Gluck et al.|British Journal of Cancer|2018Cited by 457
Biomarkers and response to pembrolizumab (pembro) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).Laura Q.M. Chow, Tanguy Y. Seiwert, Ranee Mehra et al.|Journal of Clinical Oncology|2016Cited by 31